Merck & Co., Inc., Rahway, NJ, USA and its affiliates
MSD Spain is the Spanish subsidiary of Merck & Co., Inc., developing prescription medicines and vaccines across oncology, infectious diseases, cardiometabolic conditions, and animal health. It serves healthcare professionals, hospitals, and public health programs through direct sales and digital platforms.
- Company typePublic
- Founded1891
- HeadquartersMadrid, Spain
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Merck & Co., Inc., Rahway, NJ, USA and its affiliates does
MSD Spain (legal entity Merck Sharp & Dohme de España, S.A.) is the Spanish operating subsidiary of Merck & Co., Inc. (NYSE: MRK), headquartered at C/ Josefa Valcárcel 42, Madrid, with a wholly-owned animal-health manufacturing plant in Salamanca. The subsidiary has operated in Spain for 55 years under Merck's global 130+ year history and reports €560M of human-health revenue for 2025 with 696 human-health employees in-country, against Merck's global base of approximately 75,000 employees and $15.8B of annual R&D investment. The business spans human-health prescription pharmaceuticals and vaccines across oncology, infectious diseases, cardiometabolic and respiratory conditions, and a separate animal-health franchise (MSD Animal Health — "The Science of Healthier Animals") covering veterinary pharmaceuticals, vaccines, identification, traceability, and monitoring technology.
The company's technology and platform footprint centers on clinical research and HCP digital engagement. MSD Spain was the first European subsidiary in clinical-trial participation and patients treated (2023). Its digital stack includes the MSD Profesionales Sanitarios portal delivering accredited courses, webinars, scientific articles, clinical resources, and reference manuals such as the Manual 12 de Octubre; the Panel de incidencia y tasa de vacunación application providing epidemiological incidence and vaccination-coverage data; telemedicine and digital-health tools integrating electronic health records (HCE), IoT medical devices, AI/ML analytics, and Clinical Decision Support Systems (CDSS) for HCPs. AI capabilities are used for predictive analytics on clinical and epidemiological data, NLP for scientific literature navigation, and remote patient monitoring. R&D investment in Spain reached €109M in 2024 (per Plan ProFarma).
The business model is sales-led, with enterprise field-sales through medical sales representatives targeting hospitals, clinics, and healthcare institutions. Distribution combines direct hospital and clinic supply, pharmacy wholesaling, and government public-health vaccine procurement. Revenue streams are one-time licensing of prescription medicines and vaccines across the listed therapeutic areas. Customer segments are hybrid: healthcare professionals and institutions (vertical), patients reached through the healthcare system (horizontal), and global health organizations served through access programs for HIV, COVID-19, Ebola, and neglected tropical diseases (e.g., MECTIZAN Donation Program). GTM is multi-channel, combining the HCP portal, medical congresses, email/newsletter, social media (X, LinkedIn, YouTube), and direct field engagement.
Merck & Co., Inc., Rahway, NJ, USA and its affiliates firmographics
Firmographics- Name
- Merck & Co., Inc., Rahway, NJ, USA and its affiliates
- Legal name
- Merck Sharp & Dohme de España, S.A.
- Website
- https://msd.es
- Company type
- Public
- Founded year
- 1891
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- MSD Spain is the Spanish subsidiary of Merck & Co., Inc., developing prescription medicines and vaccines across oncology, infectious diseases, cardiometabolic conditions, and animal health. It serves healthcare professionals, hospitals, and public health programs through direct sales and digital platforms.
- Ownership category
- akta.pro rank
Merck & Co., Inc., Rahway, NJ, USA and its affiliates industry classification
Industry- Product category
- Prescription Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro industry
- Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release)Vaccine R&D, Clinical/Field Trials & Regulatory AffairsTravel & Tropical Disease VaccinesVaccine Programs & Tendering (Government/NGO, Eradication Campaigns)Veterinary Pharmacy, Vaccine & Biologics Services
Keywords
Where Merck & Co., Inc., Rahway, NJ, USA and its affiliates is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
Merck & Co., Inc., Rahway, NJ, USA and its affiliates business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Pharmaceutical Products: Revenue from development and sale of prescription medicines across therapeutic areas including oncology, vaccines, infectious diseases, cardiometabolic conditions, and respiratory diseases
- Vaccines: Revenue from vaccine products for prevention of diseases including pneumococcus, rotavirus, HPV, VRS, and others
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Merck & Co., Inc., Rahway, NJ, USA and its affiliates product offering
Product offeringCore offering
MSD Spain (Merck Sharp & Dohme de España) develops and markets prescription medicines and vaccines for human health across therapeutic areas including oncology, infectious diseases, vaccines, cardiometabolic conditions, and respiratory diseases. The company also operates an Animal Health division providing veterinary pharmaceuticals, vaccines, and animal identification/traceability/monitoring technology. In addition, MSD Spain runs R&D and clinical trial operations and a digital portal for healthcare professionals.
Differentiator
Problem solved
Functional benefit
Brands
- MSD Animal Health: Animal health division offering veterinary pharmaceuticals, vaccines, and health management solutions with technology for identification, traceability, and monitoring. Branded as 'The Science of Healthier Animals'.
- MSD Profesionales Sanitarios
- MSD for Mothers
- MECTIZAN Donation Program
Products and services
- Prescription Medicines Portfolio (Human Health)
Quantifiable outcome
- MSD Spain ranked first European subsidiary in clinical trial participation and patients treated in 2023
- +2 more outcomes
Companies that use Merck & Co., Inc., Rahway, NJ, USA and its affiliates
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Merck & Co., Inc., Rahway, NJ, USA and its affiliates technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature3 records
Merck & Co., Inc., Rahway, NJ, USA and its affiliates partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, supporting and minor.
- GileadcoreCollaboration with Gilead for development of HIV treatments, working together to advance treatments for HIV patients globally
- IQVIAsupportingIQVIA Information S.A. maintains and manages the OneKey database for healthcare professional data, providing updated information on professionals and healthcare centers
- Cruz RojaminorBlood donation campaigns organized in MSD offices with support for flexible compensation framework for donations
- Banco de AlimentosminorFood collection campaigns (online and offline) and volunteer groups at MSD offices
- Fundación APASCOVIminorInitiatives to improve quality of life for people with disabilities
- Asociación ATAEMminorParticipation in two solidarity markets organized at MSD offices
- Mensajeros de la PazminorWeekly participation in solidarity breakfasts at San Antón church
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Merck & Co., Inc., Rahway, NJ, USA and its affiliates competitors and assessment
Company assessmentDirect peers
- Pfizer: Global biopharmaceutical company with parallel franchises in oncology, vaccines (incl. COVID-19), infectious diseases, and cardiometabolic. Directly comparable therapeutic areas and enterprise field-sales GTM motion across Spain and EU.
- Novartis: Swiss-headquartered pharma with overlapping therapeutic focus in oncology, cardiometabolic, and vaccines-adjacent areas. Operates in Spain through a comparable subsidiary structure with hospital-specialty sales force.
- Sanofi: Major vaccine manufacturer with parallel consumer/healthcare presence in Spain. Competes directly across MSD's vaccine portfolio (pneumococcus, HPV, RSV) and has similar EU regulatory exposure.
- GSK: Direct vaccine and specialty pharma competitor with shared focus areas (HPV, RSV, infectious disease). Comparable Spain commercial infrastructure and global health access programs.
- Roche: Major pharma competitor with leading oncology and diagnostics portfolios, similar R&D intensity, and presence in Spain. Comparable pipeline depth and hospital-channel commercial model.
- AstraZeneca: Strong overlap in oncology, vaccines, and cardiometabolic/respiratory. Operates an active Spain subsidiary with comparable R&D investment profile and clinical-trial footprint.
- Johnson & Johnson (Innovative Medicine): Diversified pharma with oncology, infectious disease, and vaccines franchises overlapping MSD's portfolio. Comparable global R&D scale and presence in Spain.
- Bristol-Myers Squibb: Oncology and immunology-focused pharma directly competing in immuno-oncology indications central to MSD's oncology franchise. Similar Spain subsidiary footprint.
- Eli Lilly: Global pharma with significant oncology and cardiometabolic overlap. Comparable R&D intensity and growing Spain presence; competes for hospital channel share.
Broad incumbents
- AbbVie: Diversified global pharma with oncology, immunology, and neuroscience focus. Less direct overlap than top peers but operates broadly in the same specialty-care space with parallel Spain operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Merck & Co., Inc., Rahway, NJ, USA and its affiliates social profiles
Digital presenceMerck & Co., Inc., Rahway, NJ, USA and its affiliates financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merck & Co., Inc., Rahway, NJ, USA and its affiliates leadership team
Management profileNumber of profiles
Profiles1 record
Merck & Co., Inc., Rahway, NJ, USA and its affiliates subsidiaries and ownership
Company hierarchySubsidiaries2 records
Merck & Co., Inc., Rahway, NJ, USA and its affiliates funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merck & Co., Inc., Rahway, NJ, USA and its affiliates M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merck & Co., Inc., Rahway, NJ, USA and its affiliates
What does Merck & Co., Inc., Rahway, NJ, USA and its affiliates do?
MSD Spain (Merck Sharp & Dohme de España) develops and markets prescription medicines and vaccines for human health across therapeutic areas including oncology, infectious diseases, vaccines, cardiometabolic conditions, and respiratory diseases. The company also operates an Animal Health division providing veterinary pharmaceuticals, vaccines, and animal identification/traceability/monitoring technology. In addition, MSD Spain runs R&D and clinical trial operations and a digital portal for healthcare professionals.
Is Merck & Co., Inc., Rahway, NJ, USA and its affiliates a public or private company?
Merck & Co., Inc., Rahway, NJ, USA and its affiliates is a public company. It is classified as public and is currently operating.
When was Merck & Co., Inc., Rahway, NJ, USA and its affiliates founded?
Merck & Co., Inc., Rahway, NJ, USA and its affiliates was founded in 1891. It employs 1,001 to 5,000 people.
Where is Merck & Co., Inc., Rahway, NJ, USA and its affiliates based?
Merck & Co., Inc., Rahway, NJ, USA and its affiliates is headquartered in Madrid, Spain, in the Europe region.
How does Merck & Co., Inc., Rahway, NJ, USA and its affiliates make money?
Two revenue lines are on record. Pharmaceutical Products are the primary driver. The others are vaccines.
Who are Merck & Co., Inc., Rahway, NJ, USA and its affiliates's main competitors?
Direct peers on record are Pfizer, Novartis, Sanofi, GSK, Roche, AstraZeneca, Johnson & Johnson (Innovative Medicine), Bristol-Myers Squibb and Eli Lilly. AbbVie is listed as a broad incumbent.
Does Merck & Co., Inc., Rahway, NJ, USA and its affiliates have an API?
No public API is recorded for Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
What industry is Merck & Co., Inc., Rahway, NJ, USA and its affiliates in?
Merck & Co., Inc., Rahway, NJ, USA and its affiliates's product category is Prescription Pharmaceuticals. Its primary akta.pro industry code is HLAAAEAK, Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release), with a secondary code of HLAMAKAM, Vaccine R&D, Clinical/Field Trials & Regulatory Affairs. Its NAICS code is 325412 and its SIC code is 2834.